The overall goal of this research is to synthesize and study hydroxamic acid based microbial iron chelators and analogues, The key to this research is the development of syntheses of the basis hydroxylamine and hydroxamic acid constituents of the natural ferric chelators (siderophores). Recent developments in this laboratory have provided efficient routes to these constituents, and a number of related versatile, but unnatural, building blocks. The utility of these approaches have been demonstrated by our synthesis of six natural siderophores and over a dozen novel analogues. This proposal will further test the generality and power of our synthetic methods by incorporating them into the synthesis of other citrate, diketopiperazine, isocyanuric acid and spermidine based siderophores and analogues. Further extensions to the synthesis of the antibiotic albomycins, and analogues of the ferrichromes and pseudobactins will illustrate the compatability of the methods with more complex molecular systems. These synthetic studies, in combination with studies of partition (transport) phenomena, biological activity, conformational effects of chelation (by NMR) and iron release mechanisms, are anticipated to facilitate a better understanding of iron metabolism in general. In addition, the hydroxamate based siderophore analogues are potential therapeutic agents for the treatment of iron overload. Others may also provide unique molecular drug delivery systems. The design of such systems (covalent siderophore, antibiotic combinations) is described.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM025845-09
Application #
3273346
Study Section
Metallobiochemistry Study Section (BMT)
Project Start
1978-12-01
Project End
1990-08-31
Budget Start
1987-09-01
Budget End
1988-08-31
Support Year
9
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Notre Dame
Department
Type
Schools of Arts and Sciences
DUNS #
824910376
City
Notre Dame
State
IN
Country
United States
Zip Code
46556
Patterson, Leslie D; Miller, Marvin J (2010) Enzymatic deprotection of the cephalosporin 3'-acetoxy group using Candida antarctica lipase B. J Org Chem 75:1289-92
Wencewicz, Timothy A; Möllmann, Ute; Long, Timothy E et al. (2009) Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin ""Trojan Horse"" antibiotics and synthetic desferridanoxamine-antibiotic conjugates. Biometals 22:633-48
Walz, Andrew J; Mollmann, Ute; Miller, Marvin J (2007) Synthesis and studies of catechol-containing mycobactin S and T analogs. Org Biomol Chem 5:1621-8
Moody, D Branch; Young, David C; Cheng, Tan-Yun et al. (2004) T cell activation by lipopeptide antigens. Science 303:527-31
Lin, Y M; Miller, M J (2001) Oxidation of primary amines to oxaziridines using molecular oxygen (O2) as the ultimate oxidant. J Org Chem 66:8282-5
Vergne, A F; Walz, A J; Miller, M J (2000) Iron chelators from mycobacteria (1954-1999) and potential therapeutic applications. Nat Prod Rep 17:99-116
Roosenberg 2nd, J M; Miller, M J (2000) Total synthesis of the siderophore danoxamine. J Org Chem 65:4833-8
Lu, Y; Miller, M J (1999) Syntheses and studies of multiwarhead siderophore-5-fluorouridine conjugates. Bioorg Med Chem 7:3025-38
Mollmann, U; Ghosh, A; Dolence, E K et al. (1998) Selective growth promotion and growth inhibition of gram-negative and gram-positive bacteria by synthetic siderophore-beta-lactam conjugates. Biometals 11:1-12
McKee, J A; Sharma, S K; Miller, M J (1991) Iron transport mediated drug delivery systems: synthesis and antibacterial activity of spermidine- and lysine-based siderophore-beta-lactam conjugates. Bioconjug Chem 2:281-91

Showing the most recent 10 out of 14 publications